Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CARAIBES CHIRURGIE BIOTECHNO MEDICALES : revenue, balance sheet and financial ratios

CARAIBES CHIRURGIE BIOTECHNO MEDICALES is a French company founded 22 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in BAIE-MAHAULT (97122), this company of category PME shows in 2021 a net income positive of 117 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CARAIBES CHIRURGIE BIOTECHNO MEDICALES (SIREN 450922539)
Indicator 2021 2020 2019
Revenue N/C N/C N/C
Net income 117 126 € 54 707 € 176 243 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2021, CARAIBES CHIRURGIE BIOTECHNO MEDICALES generates positive net income of 117 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2021: 176 k€ -> 117 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

117 126 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 426%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

425.879%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

16.525%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

11.3%

Solvency indicators evolution
CARAIBES CHIRURGIE BIOTECHNO MEDICALES

Sector positioning

Debt ratio
425.88 2021
2019
2020
2021
Q1: 0.0
Med: 8.28
Q3: 63.33
Watch

In 2021, the debt ratio of CARAIBES CHIRURGIE BIOTEC... (425.88) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
16.52% 2021
2019
2020
2021
Q1: 16.51%
Med: 37.11%
Q3: 57.43%
Average -12 pts over 3 years

In 2021, the financial autonomy of CARAIBES CHIRURGIE BIOTEC... (16.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1468.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1468.678

Liquidity indicators evolution
CARAIBES CHIRURGIE BIOTECHNO MEDICALES

Sector positioning

Liquidity ratio
1468.68 2021
2019
2020
2021
Q1: 139.0
Med: 204.34
Q3: 325.42
Excellent

In 2021, the liquidity ratio of CARAIBES CHIRURGIE BIOTEC... (1468.68) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of CARAIBES CHIRURGIE BIOTECHNO MEDICALES in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (21 transactions). This range of 21 516€ to 131 981€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2021
Indicative
21k€ 49k€ 131k€
49 504 € Range: 21 516€ - 131 981€
NAF 5 année 2021

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 21 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare CARAIBES CHIRURGIE BIOTECHNO MEDICALES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about CARAIBES CHIRURGIE BIOTECHNO MEDICALES

What is the revenue of CARAIBES CHIRURGIE BIOTECHNO MEDICALES ?

The revenue of CARAIBES CHIRURGIE BIOTECHNO MEDICALES is not publicly disclosed (confidential accounts filed with INPI).

Is CARAIBES CHIRURGIE BIOTECHNO MEDICALES profitable?

Yes, CARAIBES CHIRURGIE BIOTECHNO MEDICALES generated a net profit of 117 k€ in 2021.

Where is the headquarters of CARAIBES CHIRURGIE BIOTECHNO MEDICALES ?

The headquarters of CARAIBES CHIRURGIE BIOTECHNO MEDICALES is located in BAIE-MAHAULT (97122), in the department Guadeloupe.

Where to find the tax return of CARAIBES CHIRURGIE BIOTECHNO MEDICALES ?

The tax return of CARAIBES CHIRURGIE BIOTECHNO MEDICALES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CARAIBES CHIRURGIE BIOTECHNO MEDICALES operate?

CARAIBES CHIRURGIE BIOTECHNO MEDICALES operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.